Immunotherapy as an Option for Cancer Treatment-Reference-Cited by-同舟云学术

Immunotherapy as an Option for Cancer Treatment

Published:2017-10-12 Issue:2 Volume:66 Page:89-96
ISSN:0004-069X
Container-title:Archivum Immunologiae et Therapiae Experimentalis
language:en
Short-container-title:Arch. Immunol. Ther. Exp.

Author:

Rusch Tillmann,Bayry Jagadeesh,Werner Jens,Shevchenko Ivan,Bazhin Alexandr V.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/article/10.1007/s00005-017-0491-5/fulltext.html

Reference86 articles.

1. Alwan LM, Grossmann K, Sageser D et al (2014) Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma. Target Oncol 9:63–71

2. Amin A, White RL Jr (2013) High-dose interleukin-2: is it still indicated for melanoma and RCC in an era of targeted therapies? Oncology 27:680–691

3. Atkins MB, Lotze MT, Dutcher JP et al (1999) High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. J Clin Oncol 17:2105–2116

4. Baek S, Kim YM, Kim SB et al (2015) Therapeutic DC vaccination with IL-2 as a consolidation therapy for ovarian cancer patients: a phase I/II trial. Cell Mol Immunol 12:87–95

5. Boon T, Coulie PG, Van den Eynde B (1997) Tumor antigens recognized by T cells. Immunol Today 18:267–268

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of RNMT as an immunotherapeutic and prognostic biomarker: From pan-cancer analysis to lung squamous cell carcinoma validation;Immunobiology;2024-09

2. Recent advances in molecular targeted therapy of lung cancer: Possible application in translation medicine;IRAN J BASIC MED SCI;2024

3. Immunotherapy for colorectal cancer: Rational strategies and novel therapeutic progress;International Immunopharmacology;2024-01

4. Potential of Patient-Derived Organoids and Other 3D Culture Models to Assess Immunotherapy Response in Cancer;Handbook of Cancer and Immunology;2024

5. Recombinant antibody fragment therapeutics: Current status and future prospects of scFv, nanobody, and mimotopes;Journal of Drug Delivery Science and Technology;2023-11